That change would have allowed 3.4 million people on Medicare and about 4 million on Medicaid to gain access to the drugs
Proper counseling, labeling, and dispensing protocols are essential to reduce the risk of overdoses and associated hospitalizations
Such muscle loss can have significant implications for physical strength and functionality
doi:10.1177/20420188231222367 Gao H, Zhao Q, Tang S, Li K, Qin F, Song Z, Pan Y, Jin L, Zhang Y
The most significant clinical evidence for retatrutide to date comes from a Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023)
Ask your pharmacist if your specific insurance plan allows coordination with manufacturer programs